Response to Wirostko et al. Re: "Cross-Linked Hyaluronic Acid as Tear Film Substitute" by Posarelli et al. (J Ocul Pharmacol Ther 2019;35(7):381-387)

J Ocul Pharmacol Ther. 2020 May;36(4):206-207. doi: 10.1089/jop.2020.29067.res.
No abstract available

Publication types

  • Letter
  • Review

MeSH terms

  • Administration, Topical
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Dry Eye Syndromes / drug therapy*
  • Epidermal Growth Factor / pharmacology
  • Epithelium, Corneal / drug effects*
  • Epithelium, Corneal / injuries
  • Epithelium, Corneal / pathology
  • Fibronectins / pharmacology
  • Humans
  • Hyaluronan Receptors / metabolism
  • Hyaluronic Acid / administration & dosage
  • Hyaluronic Acid / chemistry
  • Hyaluronic Acid / pharmacology*
  • Keratoconjunctivitis Sicca / drug therapy
  • Tears / metabolism
  • Tears / physiology
  • Viscosupplements / administration & dosage
  • Viscosupplements / chemistry
  • Viscosupplements / pharmacology*
  • Wound Healing / drug effects
  • Wound Healing / immunology

Substances

  • Fibronectins
  • Hyaluronan Receptors
  • Viscosupplements
  • Epidermal Growth Factor
  • Hyaluronic Acid